Compare AVA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVA | HAE |
|---|---|---|
| Founded | 1889 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.8B |
| IPO Year | 1994 | 1996 |
| Metric | AVA | HAE |
|---|---|---|
| Price | $40.49 | $85.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $39.00 | ★ $84.13 |
| AVG Volume (30 Days) | 461.1K | ★ 595.0K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.84% | N/A |
| EPS Growth | ★ 3.93 | N/A |
| EPS | 1.11 | ★ 2.05 |
| Revenue | ★ $1,964,000,000.00 | $910,373,000.00 |
| Revenue This Year | $3.11 | N/A |
| Revenue Next Year | $4.44 | $5.23 |
| P/E Ratio | ★ $36.90 | $41.37 |
| Revenue Growth | ★ 1.34 | N/A |
| 52 Week Low | $35.50 | $47.32 |
| 52 Week High | $43.50 | $87.32 |
| Indicator | AVA | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 70.48 |
| Support Level | $40.34 | $78.87 |
| Resistance Level | $41.97 | $86.72 |
| Average True Range (ATR) | 0.78 | 2.36 |
| MACD | -0.12 | 0.56 |
| Stochastic Oscillator | 6.72 | 88.51 |
Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P segment is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.